Filing Details
- Accession Number:
- 0001567619-21-011362
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-28 16:24:48
- Reporting Period:
- 2021-05-26
- Accepted Time:
- 2021-05-28 16:24:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1804176 | Butterfly Network Inc. | BFLY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1228603 | Larry Robbins | 767 Fifth Avenue 44Th Floor New York NY 10153 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-05-26 | 150,000 | $11.09 | 4,924,846 | No | 4 | P | Indirect | See footnotes |
Class A Common Stock | Acquisiton | 2021-05-27 | 39,905 | $11.10 | 4,964,751 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 13,157 | Direct | |
Class A Common Stock | 10,275,000 | Indirect | See footnotes |
Footnotes
- These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Healthcare Master Fund, L.P.
- This price reflects the weighted average price for open-market purchases of Shares on May 26, 2021 within a $1.00 range. The actual prices for these transactions range from $11.03 to $11.13, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price.
- These shares were purchased by Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P. and Glenview Offshore Opportunity Master Fund, Ltd.
- This price reflects the weighted average price for open-market purchases of Shares on May 27, 2021 within a $1.00 range. The actual prices for these transactions range from $11.06 to $11.10, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price.
- Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the shares held by the Glenview Investment Funds and may be deemed to beneficially own such shares.
- Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these Shares. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the shares held by Longview and may be deemed to beneficially own such shares.
- Mr. Robbins disclaims beneficial ownership over any Shares owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
- Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one Share upon vesting. The RSUs vest in equal annual installments over three years beginning on February 16, 2022, subject to Mr. Robbins' continued service through the applicable vesting date.